PFE's stock price is severely undervalued.
2021 1Q: EPS annual growth rate is 41%, 2Q growth rate is 60%. If the new vaccine orders are not included, the 2Q status will be maintained. The EPS growth rate in 3Q will reach 251%, and the growth rate of EPS will reach 980% in 4Q, EPS growth rate of PFE this year has exceeded 100% at least.The P/E ratio is at least 50 times, P/E ratio is only 20 times today. The target price of PFE within one year is expected to increase by multiples.$Pfizer(PFE)$
精彩评论